Specific immunotherapy in renal cancer: a systematic review
Sign Up to like & getrecommendations! Published in 2017 at "Therapeutic Advances in Urology"
DOI: 10.1177/1756287216681246
Abstract: Background: Renal cell cancer (RCC) is the tenth most common malignancy in adults. In recent years, several approaches of active and passive immunotherapy have been studied extensively in clinical trials of patients with RCC. The… read more here.
Keywords: controlled studies; systematic review; patients rcc; review ... See more keywords
Prognostic and Clinicopathological Significance of the Systemic Immune-Inflammation Index in Patients With Renal Cell Carcinoma: A Meta-Analysis
Sign Up to like & getrecommendations! Published in 2021 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2021.735803
Abstract: Background The systemic immune-inflammation index (SII) is a hematological parameter based on neutrophil, platelet, and lymphocyte counts. Studies that have investigated the prognostic value of SII in patients with renal cell carcinoma (RCC) have reported… read more here.
Keywords: renal cell; sii; cell carcinoma; patients rcc ... See more keywords
Development and Validation of a Nomogram to Predict Distant Metastasis in Elderly Patients With Renal Cell Carcinoma
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Public Health"
DOI: 10.3389/fpubh.2021.831940
Abstract: Background Renal cell carcinoma (RCC) is the most common renal malignant tumor in elderly patients. The prognosis of renal cell carcinoma with distant metastasis is poor. We aim to construct a nomogram to predict the… read more here.
Keywords: elderly patients; metastasis elderly; predict; patients rcc ... See more keywords